News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires10d agobullish
UBS Adjusts Price Target on Biogen to $300 From $270, Keeps Buy RatingMT Newswires10d agobullish
RBC Raises Price Target on Biogen to $272 From $256, Keeps Outperform RatingMT Newswires75d agobullish
Veeva's Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings, Truist SaysSimply Wall St.79d agoneutral
Is Biogen (BIIB) Undervalued On Raised EPS Guidance And Key Phase 3 Readouts?Simply Wall St.79d agoneutral
What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For ShareholdersInvesting.com87d agobullish
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuationInvestor's Business Daily95d agoneutral
Biogen Stock: How To Find & Own America's Greatest OpportunitiesSimply Wall St.101d agoneutral
Biogen (BIIB) Is Up 5.8% After Earnings Compression Amid Revenue Growth - Is Profitability Peaking?GuruFocus.com102d agoneutral
Biogen Inc (BIIB) Q2 2026 Earnings Call Highlights: Strong Growth in Core Pharmaceuticals and ...